Education
About Us
Working with TipRanks
Follow Us
CellSource Co., Ltd. (JP:4880)
:4880
RESEARCH TOOLSreports
4880 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥556.00 - ¥1,610.00
Previous CloseN/A
Volume210.70K
Average Volume (3M)65.74K
Market Cap
¥13.83B
Enterprise Value¥78.90B
Total Cash (Recent Filing)¥4.39B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)284.5
Beta0.78
Next Earnings
Sep 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 30, 2024Dividend Yield0.72%
Share Statistics
EPS (TTM)2.86
Shares Outstanding19,812,761
10 Day Avg. Volume78,590
30 Day Avg. Volume65,743
Financial Highlights & Ratios
PEG Ratio1.46
Price to Book (P/B)21.67
Price to Sales (P/S)0.00
P/FCF Ratio109.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥880.00Price Target Upside19.89% Upside
Rating ConsensusHold
Number of Analyst Covering0
CellSource Co., Ltd. News
PremiumCompany Announcements
CellSource Co., Ltd. Sees Growth in March 2025 Contract Processing Orders
PremiumCompany Announcements
CellSource Announces Strategic Absorption-Type Split with SubsidiaryPremiumCompany Announcements
CellSource Co., Ltd. Appoints New Representative Director to Drive Growth
PremiumCompany Announcements
CellSource Faces Financial Setback Amid Service ChallengesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.41%
Mutual Funds
― Other Institutional Investors
99.50% Public Companies and
Individual Investors
4880 FAQ
What was CellSource Co., Ltd.’s price range in the past 12 months?
CellSource Co., Ltd. lowest stock price was ¥556.00 and its highest was ¥1610.00 in the past 12 months.
What is CellSource Co., Ltd.’s market cap?
CellSource Co., Ltd.’s market cap is ¥13.83B.
When is CellSource Co., Ltd.’s upcoming earnings report date?
CellSource Co., Ltd.’s upcoming earnings report date is Sep 11, 2025 which is in 90 days.
How were CellSource Co., Ltd.’s earnings last quarter?
CellSource Co., Ltd. released its earnings results on Jun 12, 2025. The company reported ¥2.86 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.86.
Is CellSource Co., Ltd. overvalued?
According to Wall Street analysts CellSource Co., Ltd.’s price is currently Undervalued.
Does CellSource Co., Ltd. pay dividends?
CellSource Co., Ltd. pays a Semiannually dividend of ¥5 which represents an annual dividend yield of 0.72%. See more information on CellSource Co., Ltd. dividends here
What is CellSource Co., Ltd.’s EPS estimate?
CellSource Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CellSource Co., Ltd. have?
CellSource Co., Ltd. has 19,812,761 shares outstanding.
What happened to CellSource Co., Ltd.’s price movement after its last earnings report?
CellSource Co., Ltd. reported an EPS of ¥2.86 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.817%.
Which hedge fund is a major shareholder of CellSource Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4880
Company Description
CellSource Co., Ltd.
CellSource Co., Ltd. (4880) is a biotechnology company based in Japan, specializing in regenerative medicine and cell therapy. The company focuses on developing and providing cellular products and services for medical institutions, research organizations, and pharmaceutical companies. Its core offerings include cell processing and storage, as well as the development of regenerative medicine products aimed at treating various diseases and injuries.
Technical Analysis
StemRIM Inc.
―
STELLA PHARMA CORPORATION
―
ReproCELL Inc.
―
StemCell Institute
―
CellSeed Inc.
―